Revision history of "Improved generic polypeptide medicines with innovative pharmaceutical forms" (Q3128065)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

10 October 2024

  • curprev 09:3009:30, 10 October 2024DG Regio talk contribs 62,519 bytes −1 Changed label, description and/or aliases in pt
  • curprev 09:3009:30, 10 October 2024DG Regio talk contribs 62,520 bytes −10 Set a claim value: summary (P836): O Projeto POLYPEPPHARM visa desenvolver 3 polipeptídeos supergénicos, nomeadamente Interferão α2a (INFα2a), Eritropoietina α (EPOa) e Interleucina 2 (IL-2), utilizando fungos metiltróficos que adicionam polissacarídeos às proteínas excretadas. As proteínas recombinantes que serão sintetizadas serão submetidas a um teste de antigenicidade e imunogenicidade, uma análise da sua estrutura e estabilidade, uma caracterização bioquímica e uma série de test...

7 March 2024

11 June 2023

17 August 2022

  • curprev 17:5817:58, 17 August 2022DG Regio talk contribs 61,805 bytes +38,102 Changed label, description and/or aliases in da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl, nl, fr, de, el, it, es, and other parts: Adding translations: da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl,

15 January 2022

17 December 2021

7 December 2021

30 November 2021

  • curprev 13:3713:37, 30 November 2021DG Regio talk contribs 15,174 bytes +2,068 Created claim: summary (P836): Le projet POLYPEPPHARM vise à développer trois polypeptides supergéniques, à savoir Interféron α2a (INFα2a), Erythropoïétine α (EPOA) et Interleukin 2 (IL-2), en utilisant des champignons méthyltrophiques qui ajoutent des polysaccharides aux protéines excrétées. Les protéines recombinantes qui seront synthétisées seront soumises à un test d’antigénicité et d’immunogénicité, à une analyse de leur structure et de leur stabilité, à une caractérisat...
  • curprev 13:3713:37, 30 November 2021DG Regio talk contribs 13,106 bytes +158 Changed label, description and/or aliases in fr: translated_label

30 September 2021

  • curprev 12:2012:20, 30 September 2021DG Regio talk contribs 12,948 bytes +431 Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string
  • curprev 09:5409:54, 30 September 2021DG Regio talk contribs 12,517 bytes +134 Changed label, description and/or aliases in en: translated_label
  • curprev 09:5409:54, 30 September 2021DG Regio talk contribs 12,383 bytes +1,852 Created claim: summary (P836): The POLYPEPPHARM Project aims to develop 3 supergenic polypeptide drugs, namely Interferon α2a (INFα2a), Erythropoietin α (EPOa), and Interleukin 2 (IL-2), using methyltrophic fungi that add polysaccharides to excreted proteins. The recombinant proteins that will be synthesised will be subjected to an antigenicity and immunogenicity test, an analysis of their structure and stability, a biochemical characterisation and a series of functionality t...

29 September 2021